This review highlights advancements in cardiac gene therapy, emphasizing the optimization of viral vectors and application techniques to improve transduction efficiency and organ specificity.
No takes yet. Share an insight, caveat, or question.
Vector optimizations may improve cardiac gene delivery; leaves open the need for clinical validation trials.
Müller et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: